AKT3 and cancer: In addition, miR-582-5p has also been reported to inhibit tumorigenesis by targeting various oncogenic events through inhibiting AKT3 [29,30,31], Rab27a [32], and TGF-β-SMAD [33] in cancer models, supporting its function as a tumor suppressor.